icon-folder.gif   Conference Reports for NATAP  
 
  17th European AIDS Conference
November 6-9
2019, Basel
Back grey_arrow_rt.gif
 
 
 
Impact of Susceptibility Scoring on Virologic Response in Heavily Treatment-Experienced Participants with HIV-1 Receiving a Fostemsavir-Based Antiretroviral Regimen: Week 96 Results from the Randomized Cohort of the Phase 3 BRIGHTE Study
 
 
  EACS 2019 Nov 6-9 Basel
Reported by Jules Levin
 
M. Lataillade1, C. Llamoso1, A. Pierce2, M. Gartland2, Mark Krystal1, S. Chabria1, Marcia Wang3, P. Ackerman1 1ViiV Healthcare, Branford, United States, 2ViiV Healthcare, Research Triangle Park, United States, 3GlaxoSmithKline, Upper Providence, United States

1118191

1118192

1118193

1118194

1118195